Abstract
Seventy-eight prepubertal, non-GH-deficient children aged 8.1 ± 0.2 y, with very short stature (mean, -3.2 SD) of intrauterine onset, were treated for 3 y with GH [0.4 (dose D1) or 1.2 (dose D2) IU/kg/wk] and 66 were followed during a 4th y without GH therapy. A 2-y intermediary report had demonstrated a GH dose-dependent acceleration of growth. During the 3rd y on GH, patients D2 (1.2 IU/kg/wk) continued with the same dose, whereas patients D1 (0.4 IU/kg/wk) were randomized to either continue on D1 (group D1) or be increased to D2 (group D1D2). After 3 y on GH, patients' mean height (SD) reached -2.37(D1), -2.17 (D1D2), and -1.58 (D2) with a total mean height gain of 0.77 (D1), 0.93 (D1D2) (difference NS), and 1.61 SD (D2 significantly higher than D1 and D1D2, p ≤ 0.0001). During the off-treatment year, mean growth rate (cm/y) decreased to 3.4 in patients D1, 3.7 in D1D2, and 4.1 in D2 (NS). During the 4 y, bone age advanced of 4.6, 4.6, and 5.3 y in D1, D1D2, and D2, respectively, and puberty started in 34 patients (10 during the off-treatment year). Age at onset of puberty, apparently within normal range, did not relate either to the dose or the duration of treatment. Clinical and biologic tolerance of treatment was good. In conclusion this study demonstrates a GH dose-dependent effect on growth acceleration in persistent postnatal severe growth retardation of intrauterine onset. This effect was sustained for 3 y at 1.2 IU/kg/wk followed by a peculiar growth deceleration at treatment discontinuation. Additional studies are necessary to optimize long-term GH treatment regimen and to document its effects on final height.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- IUGR:
-
intrauterine growth retardation
- ECP:
-
Escherichia coli protein
References
Albertsson-Wikland K 1989 Growth hormone secretion and growth hormone treatment in children with intrauterine growth retardation. Acta Paediatr Scand(suppl 349: 35–41
Lanes R, Plotnick LP, Lee PA 1979 Sustained effect of human growth hormone therapy in children with intra-uterine growth retardation. Pediatrics 63: 731–735
Rochiccioli P, Tauber M, Moison P, Pienkowski C 1989 Investigation of GH secretion in patients with IUGR. Acta Paediatr Scand(suppl 349: 42–46
Stanhope R, Preece MA, Hamill G 1991 Does growth hormone treatment improve final height attainment of children with intrauterine growth retardation?. Arch Dis Child 66: 1180–1183
Chatelain P on behalf of the International Board of KIGS 1993 Auxology and response to GH treatment of patients with IUGR or Silver-Russell syndrome: analysis of data from the KIGS. Acta Paediatr Scand( suppl 391): 79–81
Czernichow P, Rappaport R 1994 Growth Hormone and Somatomedin during Life-span, Springer, Berlin, pp 161–170
Chaussain JL, Colle M, Landier F 1994 Effects of growth hormone therapy: prepubertal children with short stature secondary to intrauterine growth retardation. Acta Paediatr Scand(suppl 399: 74–75
Chatelain P, Job JC, Blanchard J, Ducret JP, Olivier M, Sagnard L, Vanderschueren-Lodeweyckx on behalf of the Belgian and French Pediatric Clinics and Sanofi 1994 Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth-retarded children. J Clin Endocrinol Metabol 78: 1454–1460
Albanese A, Stanhope R 1993 Growth and metabolic data following growth hormone treatment of children with intrauterine growth retardation. Horm Res 39: 8–12
Usher R, Mc Lean F 1969 Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 wk of gestation. J Pediatr 74: 901–910
Sempe M, Pedron G, Roy MP 1979 Auxologie, Méthodes et séquences. Theraplix publ., Paris
Marshall WA, Tanner JM 1969 Variations in the pattern of pubertal changes in girls. Arch Dis Child 44: 291–303
Marshall WA, Tanner JM 1970 Variations in the pattern of pubertal changes in boys. Arch Dis Child 45: 13–23
Greulich WW, Pyle SI 1959 Radiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd Ed. Stanford University Press, Stanford, CA
Tanner JM, Lejarriaga H, Cameron N 1975 The natural history of the Silver-Russell syndrome: a longitudinal study of 39 cases. Pediatr Res 9: 611–623
Job JC, Rolland A 1986 Histoire naturelle des retards de croissance a debut intrauterin. Arch Fr Pediatr 43: 301–306
Davies PSW, Valley R, Preece MA 1988 Adolescent growth and pubertal progression in the Silver-Russell syndrome. Arch Dis Child 63: 130–135
DeWaal WJ, HokkenKoelega ACS, Stijnen T, KeizerSchrama SMPFD, Drop SLS 1994 Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intra-uterine growth retardation. Clin Endocrinol 41: 621–630
Chaussain JL, Colle M, Ducret JP 1994 Adult height in children with prepubertal short stature secondary to intrauterine growth retardation. Acta Paediatr Scand(suppl 399: 72–73
Karlberg J, Albertsson-Wikland K 1995 Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res 38: 733–739
Author information
Authors and Affiliations
Additional information
Participating pediatric clinics in Belgium: Antwerpen (M. DuCaju), Brussels(C. Heinrich, G. Van Vliet), Gent (M. Craen), Liège (L. Thiry), and in France: Bordeaux (M. Colle), Paris (F. Girard, J. E. Toublanc), Rennes (M. Lecornu), Strasbourg (J. G. Juif), Tours (F. Despert). Participating persons in the Sanofi-Choay staff in France: J. Blanchard, P. Carita, S. Claudel, E. Masuy, and L. Sagnard.
Rights and permissions
About this article
Cite this article
Job, J., Chaussain, J., Job, B. et al. Follow-Up of Three Years of Treatment with Growth Hormone and of One Post-Treatment Year, in Children with Severe Growth Retardation of Intrauterine Onset. Pediatr Res 39, 354–359 (1996). https://doi.org/10.1203/00006450-199602000-00027
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199602000-00027
This article is cited by
-
Growth hormone treatment for short stature in children born small for gestational age
Advances in Therapy (2008)
